MEDULLOBLASTOMA RECURRENT
Clinical trials for MEDULLOBLASTOMA RECURRENT explained in plain language.
Never miss a new study
Get alerted when new MEDULLOBLASTOMA RECURRENT trials appear
Sign up with your email to follow new studies for MEDULLOBLASTOMA RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with relapsed brain cancer: experimental drug trial opens
Disease control Not yet recruitingThis study is testing a drug called liothyronine (L-T3), both alone and combined with standard chemotherapy, for children and young adults whose medulloblastoma brain cancer has come back or gotten worse after initial treatment. The first part of the trial aims to find a safe dos…
Matched conditions: MEDULLOBLASTOMA RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: Sabine Mueller, MD, PhD • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New 'Living Drug' trial offers hope for kids with tough brain cancers
Disease control Not yet recruitingThis early-stage study is testing a new type of personalized cell therapy called B7-H3 CAR T cells in children and young adults whose brain tumors have come back or gotten worse. The main goals are to find a safe dose and see if the body can successfully make the treatment. Parti…
Matched conditions: MEDULLOBLASTOMA RECURRENT
Phase: PHASE1 • Sponsor: Robbie Majzner • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC